Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

The Mobile Police Department is looking for a third teen in connection with a Halloween night shooting that claimed the life ...

Arcturus Therapeutics expects interim results for LUNAR-CF and LUNAR-OTC in 2025. Learn why ARCT stock presents an ...

Forty-four-year-old Anthony Green is accused of shooting another man multiple times during an argument on Nov. 4, 2024. Nyyon ...

This story has been updated to remove the name of a 14-year-old suspect due to him no longer being a public safety threat.

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Intrigue surrounding the outcome of an ExxonMobil wildcat in Angola’s frontier Namibe basin continues to build, more than ...

HC Wainwright reaffirmed their buy rating on shares of Arcturus Therapeutics (NASDAQ:ARCT – Free Report) in a research report ...

Arcturus Therapeutics (ARCT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ed ...

Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) have earned an average recommendation of “Buy” ...

Arcturus Therapeutics (ARCT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on November 7. Analyst Lili (Aurélie) Nsongo from Leerink Partners maintained a ...

1 strain in Japan and for the continued success of the STARR® platform in multiple Phase 3 trials, underscoring CSL and Arcturus’ commitment to deliver disruptive technologies for protection ...